TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7962442

Group type: EXPERIMENTAL
Intervention: Investigated for antiphospholipid antibodies (APA), polycystic ovaries (PCO), hypersecretion of luteinizing hormone (LH), and chromosome abnormalities.
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Ultrasound diagnosis of PCO
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Early morning urinary LH analysis
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Testing for circulating APA
Number of subjects: 500
Study: 3311439

Group type: EXPERIMENTAL
Intervention: Two-tablet regimen (500 mg mefloquine, 1000 mg sulfadoxine, 50 mg pyrimethamine)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Three-tablet regimen (750 mg mefloquine, 1500 mg sulfadoxine, 75 mg pyrimethamine)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 89
Study: 31898521

Group type: EXPERIMENTAL
Intervention: ATRA-RIF (oral arsenic realgar-indigo naturalis formula)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ATRA-ATO (intravenous arsenic trioxide)
Number of subjects: 0
Study: 31015214

Group type: EXPERIMENTAL
Intervention: Simulation training
Number of subjects: 112

Group type: COMPARATOR
Intervention: Routine clinical use of M‐CPR
Number of subjects: 112
Study: 29231432

Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with rehabilitation
Number of subjects: 184

Group type: COMPARATOR
Intervention: Rehabilitation (conventional physical training and massage)
Number of subjects: 184
Study: 26279077

Group type: EXPERIMENTAL
Intervention: Midazolam 0.02 mg/kg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Midazolam (exact dosage not specified for group M1)
Number of subjects: 18
Study: 23776445

Group type: EXPERIMENTAL
Intervention: Ketamine administration during memory testing after Pavlovian fear conditioning
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo administration during memory testing after Pavlovian fear conditioning
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ketamine administration
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Appetitive learning procedure with ketamine
Number of subjects: 18
Study: 21484867

Group type: EXPERIMENTAL
Intervention: AFQ056 25-150 mg twice daily for 16 days (study 1)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: AFQ056 25-150 mg twice daily for 16 days (study 2)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: AFQ056
Number of subjects: 59
Study: 19450052

Group type: EXPERIMENTAL
Intervention: Chronic oral anticoagulation (e.g., warfarin or dicoumarol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral antiplatelet agents
Number of subjects: 0
Study: 16410042

Group type: EXPERIMENTAL
Intervention: Facilitated tucking by parents
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control care (without facilitated tucking)
Number of subjects: 20
Study: 15320653

Group type: EXPERIMENTAL
Intervention: Women soccer players
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sedentary women
Number of subjects: 34
Study: 11240956

Group type: EXPERIMENTAL
Intervention: Intradermal injection of killed Mycobacterium vaccae (SRL 172)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (buffer solution)
Number of subjects: 41
Study: 9259191

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (48-hour infusion)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Isotonic glucose (placebo)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (48-hour infusion) in elderly patients (> 70 years)
Number of subjects: 194
Study: 8100345

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU retinol equivalent; 100,000 IU for children under 12 months) every 4 months
Number of subjects: 21906
Study: 3544807

Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical expansion
Number of subjects: 0
Study: 31087093

Group type: EXPERIMENTAL
Intervention: Digital behavioral pain medicine intervention (MSS)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Digital general health education (HE)
Number of subjects: 68
Study: 28296750

Group type: EXPERIMENTAL
Intervention: All-arthroscopic (AA) repair
Number of subjects: 100

Group type: COMPARATOR
Intervention: Mini-open (MO) repair
Number of subjects: 100
Study: 25673148

Group type: EXPERIMENTAL
Intervention: Diphenhydramine-containing medication (25 mg diphenhydramine, 10 mg phenylephrine)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Dextromethorphan syrup (30 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 22
Study: 24305660

Group type: EXPERIMENTAL
Intervention: Ginger compress
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ginger patch
Number of subjects: 20
Study: 21423025

Group type: EXPERIMENTAL
Intervention: Extended daily NVP (ExtNVP) through 14 weeks
Number of subjects: 3126

Group type: EXPERIMENTAL
Intervention: Extended daily NVP + ZDV (ExtNVP/ZDV) through 14 weeks
Number of subjects: 3126

Group type: COMPARATOR
Intervention: Control (single-dose nevirapine + 1-week zidovudine)
Number of subjects: 3126

Group type: EXPERIMENTAL
Intervention: Extended arms (ExtNVP and ExtNVP/ZDV combined)
Number of subjects: 3126
Study: 19374309

Group type: EXPERIMENTAL
Intervention: Lower extremity functional exercise (forward step up, lateral step up, heel raise, lunge) for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 20
Study: 17563161

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antidepressant medication (ADM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High post acute treatment levels of decentering and low cognitive reactivity
Number of subjects: 0
Study: 15334612

Group type: EXPERIMENTAL
Intervention: 9.6 μm TEA CO2 laser (2.4 or 4.8 J delivered for 20 or 40 seconds)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham dental procedure (positive control)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No procedure (negative control)
Number of subjects: 24
Study: 11354586

Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Contact
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Protest
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control
Number of subjects: 152
Study: 10881755

Group type: EXPERIMENTAL
Intervention: 4-week disease-management program ('Women take PRIDE')
Number of subjects: 570

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 570
Study: 7886986

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol 4000 (PEG) 60g/d
Number of subjects: 8
Study: 2590918

Group type: EXPERIMENTAL
Intervention: Normothermia (34 degrees C) with empty beating heart
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Hypothermia (27-33 degrees C) with ventricular fibrillation
Number of subjects: 2
Study: 142248

Group type: EXPERIMENTAL
Intervention: Tilidine (100 mg i.m.)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Pethidine (100 mg i.m.)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Tilidine (Valoron)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Pethidine (Dolantin)
Number of subjects: 99
Study: 31558161

Group type: EXPERIMENTAL
Intervention: Occupational stress measured using the Osipow Occupational Stress Questionnaire
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Subscale of 'Role Overload'
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Subscale of 'Physical Environment'
Number of subjects: 155

Group type: COMPARATOR
Intervention: Demographic variables (sex, age, academic degree, working experience)
Number of subjects: 155
Study: 27863320

Group type: EXPERIMENTAL
Intervention: Childhood adversity (specifically physical abuse)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Childhood adversity (specifically emotional neglect)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Childhood adversity
Number of subjects: 105
Study: 26124508

Group type: COMPARATOR
Intervention: Standard quitline treatment
Number of subjects: 1785

Group type: EXPERIMENTAL
Intervention: Standard plus technology enhanced quitline with 10 risk assessments (TEQ-10)
Number of subjects: 1785

Group type: EXPERIMENTAL
Intervention: Standard plus 20 TEQ assessments (TEQ-20)
Number of subjects: 1785
Study: 24073645

Group type: EXPERIMENTAL
Intervention: Norditropin FlexPro (FP) pen
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Norditropin NordiFlex (NF) pen
Number of subjects: 64

Group type: COMPARATOR
Intervention: Genotropin GoQuick (GQ) pen
Number of subjects: 64
Study: 21782218

Group type: EXPERIMENTAL
Intervention: Barbed polyglyconate suture
Number of subjects: 64

Group type: COMPARATOR
Intervention: Monofilament poliglecaprone suture
Number of subjects: 64
Study: 19519885

Group type: COMPARATOR
Intervention: MAMS methodology
Number of subjects: 0

Group type: COMPARATOR
Intervention: MAMS design
Number of subjects: 0
Study: 17186000

Group type: EXPERIMENTAL
Intervention: Buspirone 60 mg p.o. co-administered with morphine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo co-administered with morphine
Number of subjects: 12
Study: 15347373

Group type: EXPERIMENTAL
Intervention: Desloratadine (5 mg) plus montelukast (10 mg)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Desloratadine (5 mg) plus placebo
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo alone
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Desloratadine (5 mg)
Number of subjects: 81
Study: 11133873

Group type: EXPERIMENTAL
Intervention: ILM removal (ILM-off group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No ILM removal (ILM-on group)
Number of subjects: 48
Study: 9772141

Group type: EXPERIMENTAL
Intervention: Cooked egg protein (25 g of cooked 13C- and 15N-labeled egg protein)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Raw egg protein (25 g of raw egg protein)
Number of subjects: 5
Study: 7839722

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 1838

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1838
Study: 2485986

Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Psychotherapy with placebo
Number of subjects: 100
Study: 1351

Group type: EXPERIMENTAL
Intervention: Visken (beta-receptor blocking agent)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31916011

Group type: EXPERIMENTAL
Intervention: One-handed ventilation with an endoscopic bite block
Number of subjects: 59

Group type: COMPARATOR
Intervention: One-handed ventilation
Number of subjects: 59

Group type: COMPARATOR
Intervention: Two-handed ventilation
Number of subjects: 59

Group type: COMPARATOR
Intervention: All ventilation techniques
Number of subjects: 59
Study: 30887965

Group type: EXPERIMENTAL
Intervention: 10% ethanolic extract of propolis
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 30% ethanolic extract of propolis
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Single Bond Universal dentin bonding agent
Number of subjects: 96

Group type: COMPARATOR
Intervention: Distilled water (placebo)
Number of subjects: 96
Study: 28166725

Group type: EXPERIMENTAL
Intervention: Complex intervention including practice-based case management, self-management of OAT, and additional patient and practice team education
Number of subjects: 736

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 736
Study: 25062713

Group type: EXPERIMENTAL
Intervention: Pitavastatin (2 mg/day)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 104
Study: 23644851

Group type: EXPERIMENTAL
Intervention: 7.2% hypertonic saline - 6% hydroxyethyl starch (HS-HES) solution
Number of subjects: 40

Group type: COMPARATOR
Intervention: 6% hydroxyethyl starch (HES) solution
Number of subjects: 40
Study: 21144516

Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian drilling (LOD)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (fertile regularly menstruating women)
Number of subjects: 26
Study: 19934563

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field therapy (PEMF) for 30 sessions (45 minutes each) at a frequency of 1 Hz and current intensity of 30 mili ampere.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham treatment for 30 sessions (45 minutes each).
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field therapy (PEMF)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 12
Study: 17032714

Group type: EXPERIMENTAL
Intervention: GH 0.1 IU/kg per day
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: GH 0.2 IU/kg per day
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 15486358

Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT) - treadmill and cycle exercise, n = 9
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combined Aerobic and Strength Training (COMT) - treadmill and cycle exercise plus upper- and lower-extremity strength training, n = 9
Number of subjects: 18
Study: 11482341

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 2x 1 g daily
Number of subjects: 56

Group type: COMPARATOR
Intervention: Cyclosporin A (CsA) aiming at blood trough levels of 120-150 ng/ml
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Cyclosporin A (CsA)
Number of subjects: 56
Study: 9591815

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% gel
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.05% gel
Number of subjects: 348

Group type: COMPARATOR
Intervention: Fluocinonide 0.05% cream
Number of subjects: 348
Study: 7820892

Group type: EXPERIMENTAL
Intervention: Econazole
Number of subjects: 102

Group type: COMPARATOR
Intervention: Clotrimazole
Number of subjects: 102
Study: 3236268

Group type: EXPERIMENTAL
Intervention: Bronchodilation suggestion
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bronchoconstriction suggestion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Neutral suggestion
Number of subjects: 30
Study: 31087132

Group type: EXPERIMENTAL
Intervention: Standard therapy including glucocorticoids and methotrexate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Refractory JDM treatments including azathioprine, ciclosporin, intravenous immune globulins, mycophenolate mofetil, and rituximab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Validated tools for assessing disease activity, disease damage, and treatment responses
Number of subjects: 0
Study: 30018221

Group type: EXPERIMENTAL
Intervention: School nutrition intervention (classroom-based education sessions and provision of locally-prepared healthy snacks)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: School nutrition intervention
Number of subjects: 296

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 296
Study: 26490677

Group type: EXPERIMENTAL
Intervention: Targeted five-cut CT scan protocol with low radiation exposure (0.002 mSv)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: AOFAS scores obtained at a minimum of 1 year after surgery
Number of subjects: 36

Group type: COMPARATOR
Intervention: Contralateral ankle used as control
Number of subjects: 36
Study: 23790592

Group type: EXPERIMENTAL
Intervention: MIG welding of aluminium
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: MIG soldering of zinc coated materials
Number of subjects: 12

Group type: COMPARATOR
Intervention: Filtered ambient air
Number of subjects: 12
Study: 22653043

Group type: EXPERIMENTAL
Intervention: RenalGuard therapy (hydration with saline and NAC controlled by the RenalGuard System and furosemide)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Sodium bicarbonate solution and N‐acetylcysteine (NAC) (Control group)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: RenalGuard therapy
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 292
Study: 19887054

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (normotensive healthy persons)
Number of subjects: 30
Study: 17261422

Group type: EXPERIMENTAL
Intervention: Target hemoglobin level of 13 to 15 g/dL (group 1)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Target hemoglobin level of 10.5 to 11.5 g/dL (group 2)
Number of subjects: 172
Study: 15297194

Group type: EXPERIMENTAL
Intervention: Concurrent cisplatin and radiotherapy (RT)
Number of subjects: 494
Study: 11260007

Group type: EXPERIMENTAL
Intervention: SDZ ASM 981 1% cream
Number of subjects: 16

Group type: COMPARATOR
Intervention: Betamethasone‐17‐valerate 0.1% cream
Number of subjects: 16

Group type: COMPARATOR
Intervention: Triamcinolone acetonide 0.1% cream
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vehicle of SDZ ASM 981 1% cream
Number of subjects: 16
Study: 9558039

Group type: EXPERIMENTAL
Intervention: 4‐Methylpyrazole (4‐MP), 15 mg/kg body weight dissolved in 50 ml of orange juice
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 4‐Methylpyrazole (4‐MP)
Number of subjects: 14
Study: 7520209

Group type: EXPERIMENTAL
Intervention: tissue-type plasminogen activator (t-PA)
Number of subjects: 103

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: ST depression
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: No ST depression
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: ejection fraction
Number of subjects: 103
Study: 3243929

Group type: EXPERIMENTAL
Intervention: Tianeptine (12.5 mg) administered after fasting
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tianeptine (12.5 mg) administered after a standardized breakfast
Number of subjects: 12
Study: 31008744

Group type: EXPERIMENTAL
Intervention: Silver-containing hydrofiber dressings
Number of subjects: 60
Study: 28361616

Group type: EXPERIMENTAL
Intervention: Endovascular treatment plus standard medical therapy
Number of subjects: 344

Group type: COMPARATOR
Intervention: Standard medical therapy alone
Number of subjects: 344
Study: 25933031

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Alendronate 70 mg weekly
Number of subjects: 25
Study: 23579816

Group type: EXPERIMENTAL
Intervention: Tamoxifen therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21336108

Group type: EXPERIMENTAL
Intervention: Terlipressin (1 mg over 30 mins followed by continuous infusion of 2 μg·kg(‐1)·h(‐1) for 48 hrs)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 30
Study: 19858438

Group type: EXPERIMENTAL
Intervention: High social support treatment
Number of subjects: 193

Group type: COMPARATOR
Intervention: Low social support treatment
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Family index participants
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Individual index participants
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Overall intention-to-treat
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: High support group with partners attending more counseling sessions
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Low support group with partners attending more counseling sessions
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: High support group with partners losing at least 5% of baseline weight
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Low support group with partners losing at least 5% of baseline weight
Number of subjects: 193
Study: 17805438

Group type: EXPERIMENTAL
Intervention: 0.25% levobupivacaine
Number of subjects: 68

Group type: COMPARATOR
Intervention: 0.25% ropivacaine
Number of subjects: 68
Study: 15450119

Group type: EXPERIMENTAL
Intervention: 50 mcg vaginal misoprostol
Number of subjects: 163

Group type: COMPARATOR
Intervention: 3 mg dinoprostone
Number of subjects: 163
Study: 10931388

Group type: EXPERIMENTAL
Intervention: Conventional immunotherapy (IT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tetanus toxoid (TT) stimulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Allergic control patients (AC group)
Number of subjects: 10
Study: 9065532

Group type: EXPERIMENTAL
Intervention: ADHD subjects
Number of subjects: 30
Study: 8218956

Group type: EXPERIMENTAL
Intervention: Innovator product (Negram‐Winthrop‐Breon)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Two products with lower bioavailability
Number of subjects: 12
Study: 2947106

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study: 31574585

Group type: EXPERIMENTAL
Intervention: Relaxation intervention (RELAX; face‐to‐face classes and daily home practice of progressive muscle relaxation and mindfulness meditation)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Wait-list control (CON)
Number of subjects: 36
Study: 29588187

Group type: EXPERIMENTAL
Intervention: Chlorhexidine baths
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (before implementation of chlorhexidine baths)
Number of subjects: 0
Study: 27320058

Group type: EXPERIMENTAL
Intervention: Bevacizumab (52.6%, n = 49)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ranibizumab (44.1%, n = 41)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Pegaptanib (7.5%, n = 7)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Aflibercept (5.4%, n = 5)
Number of subjects: 93
Study: 24315218

Group type: EXPERIMENTAL
Intervention: Brief motivational enhancement intervention (up to 5 sessions lasting 10-30 minutes each)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 330
Study: 23598289

Group type: EXPERIMENTAL
Intervention: Oxytocin 5 U
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Carbetocin 100 μg
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 20675978

Group type: EXPERIMENTAL
Intervention: CER 15 mg
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: CER 30 mg
Number of subjects: 504

Group type: COMPARATOR
Intervention: CIR 10 mg
Number of subjects: 504

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 504
Study: 17405870

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Assisted-control ventilation plus volume guarantee (VG) (Vt = 5 ml/kg)
Number of subjects: 40